M. Gérardin

751 total citations
21 papers, 414 citations indexed

About

M. Gérardin is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, M. Gérardin has authored 21 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Psychiatry and Mental health. Recurrent topics in M. Gérardin's work include Cystic Fibrosis Research Advances (16 papers), Child Nutrition and Feeding Issues (4 papers) and Neonatal Respiratory Health Research (4 papers). M. Gérardin is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Child Nutrition and Feeding Issues (4 papers) and Neonatal Respiratory Health Research (4 papers). M. Gérardin collaborates with scholars based in France. M. Gérardin's co-authors include À. Munck, Muriel Lebourgeois, Jean Navarro, Isabelle Sermet‐Gaudelus, N. Brahimi, Édouard Bingen, Stéphane Bonacorsi, Muriel Le Bourgeois, Patricia Mariani‐Kurkdjian and I. Duguépéroux and has published in prestigious journals such as European Respiratory Journal, Journal of Adolescent Health and Journal of Pediatric Surgery.

In The Last Decade

M. Gérardin

21 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Gérardin France 9 281 77 66 63 52 21 414
Beth Sufian United States 3 384 1.4× 79 1.0× 52 0.8× 48 0.8× 8 0.2× 4 452
Gary M. Onady United States 10 500 1.8× 77 1.0× 36 0.5× 157 2.5× 14 0.3× 22 703
Stefanie J. Millar United States 14 821 2.9× 59 0.8× 40 0.6× 30 0.5× 65 1.3× 30 910
Ranjith Kamity United States 8 104 0.4× 26 0.3× 55 0.8× 39 0.6× 13 0.3× 16 242
Meghan E. McGarry United States 12 412 1.5× 38 0.5× 36 0.5× 19 0.3× 14 0.3× 25 518
Una O'Hea United Kingdom 7 202 0.7× 17 0.2× 26 0.4× 81 1.3× 26 0.5× 8 334
Carol Brunzell United States 5 404 1.4× 58 0.8× 22 0.3× 161 2.6× 6 0.1× 7 557
José Valverde‐Molina Spain 11 168 0.6× 20 0.3× 38 0.6× 31 0.5× 30 0.6× 34 400
Henry Levison Canada 6 538 1.9× 28 0.4× 37 0.6× 56 0.9× 16 0.3× 8 620
Antonela Martínez-Torres Spain 9 166 0.6× 23 0.3× 34 0.5× 38 0.6× 49 0.9× 11 441

Countries citing papers authored by M. Gérardin

Since Specialization
Citations

This map shows the geographic impact of M. Gérardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gérardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gérardin more than expected).

Fields of papers citing papers by M. Gérardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gérardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gérardin. The network helps show where M. Gérardin may publish in the future.

Co-authorship network of co-authors of M. Gérardin

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gérardin. A scholar is included among the top collaborators of M. Gérardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gérardin. M. Gérardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bokov, Plamen, et al.. (2022). Beneficial short-term effect of autogenic drainage on peripheral resistance in childhood cystic fibrosis disease. BMC Pulmonary Medicine. 22(1). 241–241. 2 indexed citations
2.
Clainche, Laurence Le, et al.. (2021). Very early glucose tolerance abnormalities in children with cystic fibrosis. Journal of Cystic Fibrosis. 20(5). 792–795. 2 indexed citations
3.
Reix, Philippe, Aurélie Tatopoulos, Iulia Ioan, et al.. (2021). Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis. 21(1). 155–159. 8 indexed citations
4.
Bokov, Plamen, et al.. (2021). Impulse oscillometry indices to detect an abnormal lung clearance index in childhood cystic fibrosis. Pediatric Pulmonology. 56(12). 3752–3757. 9 indexed citations
5.
Gérardin, M., et al.. (2021). Phenotypic Presentations of Cystic Fibrosis in Children of African Descent. Genes. 12(3). 458–458. 3 indexed citations
6.
Chatron, Eva, Quitterie Reynaud, Sandrine Touzet, et al.. (2020). Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients. Journal of Cystic Fibrosis. 19(5). 712–716. 48 indexed citations
7.
Gérardin, M., et al.. (2018). A quality improvement program for adolescents with cystic fibrosis: focus on psychosocial skills. Orphanet Journal of Rare Diseases. 13(S1). 7–7. 5 indexed citations
8.
Debray, Dominique, et al.. (2016). Atteinte hépatique, digestive, prise en charge nutritionnelle et troubles de l'oralité chez l'enfant atteint de mucoviscidose. Archives de Pédiatrie. 23(12). 12S15–12S20. 6 indexed citations
9.
Gérardin, M., et al.. (2015). WS03.3 Preparing first school entry for a child with cystic fibrosis: Contribution of a group education session. Journal of Cystic Fibrosis. 14. S5–S5. 1 indexed citations
10.
Munck, À., et al.. (2011). Recurrent abdominal pain in children with cystic fibrosis: A pilot prospective longitudinal evaluation of characteristics and management. Journal of Cystic Fibrosis. 11(1). 46–48. 12 indexed citations
11.
Munck, À., Frédéric Huet, Nathalie Wizla, et al.. (2010). A new water-soluble oral vitamin E formulation in cystic fibrosis (CF) children. Journal of Cystic Fibrosis. 9. S91–S91. 5 indexed citations
12.
Jacquemin, Emmanuel, B. Hermeziu, F. Le Coz, et al.. (2009). Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. Journal of Clinical Pharmacy and Therapeutics. 34(5). 515–522. 28 indexed citations
13.
Duguépéroux, I., Aline Tamalet, Isabelle Sermet‐Gaudelus, et al.. (2008). Clinical Changes of Patients with Cystic Fibrosis during Transition from Pediatric to Adult Care. Journal of Adolescent Health. 43(5). 459–465. 71 indexed citations
14.
Munck, À., M. Gérardin, Corinne Alberti, et al.. (2006). Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study. Journal of Pediatric Surgery. 41(9). 1556–1560. 27 indexed citations
15.
Munck, À., S. Malbezin, M. Gérardin, et al.. (2004). Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. European Respiratory Journal. 23(3). 430–434. 65 indexed citations
16.
Delaisi, Bertrand & M. Gérardin. (2003). [In clinical practice].. PubMed. 53(2). 171–3. 13 indexed citations
17.
Munck, À., Stéphane Bonacorsi, Patricia Mariani‐Kurkdjian, et al.. (2001). Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatric Pulmonology. 32(4). 288–292. 94 indexed citations
18.
Munck, À., Muriel Le Bourgeois, M. Gérardin, & Jean Navarro. (1998). Mucoviscidose : diététique et support nutritionnel. Nutrition Clinique et Métabolisme. 12(4). 283–288. 6 indexed citations
19.
Munck, À., et al.. (1997). [Mucoviscidosis. Nutritional management].. PubMed. 26(15). 721–6. 1 indexed citations
20.
Bonacorsi, Stéphane, À. Munck, M. Gérardin, et al.. (1996). In situ management and molecular analysis of candidaemia related to a totally implantable vascular access in a cystic fibrosis patient. Journal of Infection. 33(1). 49–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth Sufian Breakdown of academic impact, for papers by Gary M. Onady Breakdown of academic impact, for papers by Stefanie J. Millar Breakdown of academic impact, for papers by Ranjith Kamity Breakdown of academic impact, for papers by Meghan E. McGarry Breakdown of academic impact, for papers by Una O'Hea Breakdown of academic impact, for papers by Carol Brunzell Breakdown of academic impact, for papers by José Valverde‐Molina Breakdown of academic impact, for papers by Henry Levison Breakdown of academic impact, for papers by Antonela Martínez-Torres
Rankless by CCL
2026